- Dec 17, 2020- Abbott's HeartMate 3™ heart pump approved for use for pediatric patients battling advanced heart failure- This life-saving technology provides new treatment option for underserved population
Dec 16, 2020- First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes- Abbott and eMed™ expect to deliver and administer 30 million BinaxNOW™ tests in the first quarter of 2021, with an additional 90 million in the second quarter- $25 cost for the test and service is the lowest available for at-home testing, which supports the home user to ensure a successful testing process- BinaxNOW is a highly portable, easy-to-use, 15-minute antigen test with no instrument that detects the virus when people are most infectious, which is critically important in slowing the spread of the virus- Service uses Abbott's complementary NAVICA™ app to enable the testing process and display authenticated BinaxNOW test results verified by a trained guide - and supports consumer confidence in testing at home- Dec 15, 2020- SARS-CoV-2 IgG II Quant antibody test measures levels of IgG antibodies to help measure and understand a person's immune response- The test specifically identifies levels of IgG antibodies that attach to the virus' spike protein which can be helpful to evaluate a person's immune response to vaccines- CE Mark test will be available for use on Abbott's ARCHITECT® and Alinity i™ platforms- Abbott plans to submit its test for U.S. Food and Drug Administration (FDA) emergency use authorization soon
- Dec 14, 2020- New product contains zinc, prebiotics and vitamins B12, C and E- Abbott expands its Pedialyte product portfolio with four new product introductions: Pedialyte with Immune Support, Pedialyte Sport, Pedialyte Organic and Pedialyte Electrolyte Water with Zero Sugar